No Data
No Data
Bike King positively reacted to the significant upward revision of its Financial Estimates.
The largest motorcycle buying company, Bike King & Company <3377.T>, saw its stock rise by 50 yen to 564 yen. After the market close on the 6th, an upward revision of the financial estimates for the fiscal year ending November 2024 was announced, which was viewed as a positive buying factor. The full-year consolidated operating profit and loss estimates were raised from a profit of 120 million yen to a profit of 286 million yen (compared to a loss of 166 million yen in the previous period, standalone). The company contributed by controlling advertising costs, while the auction market remained more stable than expected and securing inventory helped as well.
January 7 [Today's Investment Strategy]
[Fisco Selected Stock] 【Material Stock】 Asteria <3853> 529 yen (1/6) develops Software and services to connect Computers and devices within companies. The performance Financial Estimates for the fiscal year ending March 2025 have been revised. Operating profit is estimated at 0.6 billion yen. This is an increase of 9-50% from the previous estimate. The previous year had a deficit of 3.642 billion yen. The expected profits in the Software business compared to initial estimates are a contributing factor. Additionally, the policy for Shareholder returns has been changed, with the end-of-term Dividends set at 7.5 yen. The previous estimate was
Bike King, Cyber ◆ Today's Fisco Hot Stocks ◆
Bike King <3377> announced a revision of its Financial Estimates for the fiscal year ending in November 2024. Revenue is expected to decrease from 35.6 billion yen to 33.965 billion yen, but operating profit has been revised upward from 0.12 billion yen to 0.286 billion yen. In the fourth quarter accounting period, while increasing advertising expenses aimed at boosting the number of units purchased, spending was managed more than anticipated, while auction prices remained stable compared to expectations. Additionally, retail enhancements were promoted, and inventory was secured in preparation for the next period.
Attention is focused on Asteria and Dai-Seki, while Azuwan and Nextage are showing weakness.
In the US stock market on the 6th, the Dow Jones Industrial Average fell by $25.57 to 42,706.56, the Nasdaq Composite Index rose by 243.30 points to 19,864.98, and the Chicago Nikkei 225 Futures were up 335 yen compared to the daytime in Osaka at 39,675 yen. The exchange rate was 1 dollar = 157.50-60 yen. In today's Tokyo market, Asteria <3853>, which revised its operating profit and Dividends Financial Estimates upward for the fiscal year ending March 2025, Dai-Seki <9793>, which revised its operating results and Dividends Financial Estimates upward for the fiscal year ending February 2025, and the Social Medical Corporation Seishinkai Sapporo Seiji.
<Today's individual materials> WOLVES, Canvas, Right-On, Dai-seki, ETC (Announced on the 6th)
▽WOLVES <194A.T> has resolved to acquire the operations of Yasuda Animal Hospital (Nishinomiya City, Hyogo Prefecture) and signed a business transfer agreement. ▽Canvas <4575.T> has received a patent grant from the U.S. Patent Office for the immunotherapy candidate compound "CBT005". ▽Right-On <7445.T> reported that same-store sales in December decreased by 15.4% compared to the same month last year, marking the tenth consecutive month below the previous year. ▽Daiseki S <1712.T> has reported the cumulative results for the third quarter of the period ending February 25 (March-November 24).
Kaneko Seeds, Nakakita Manufacturing, Right-On, and Yakuodo HD (on the 7th).
The above Calendar is only a schedule and may be subject to change due to the company's circumstances. --------------------------------------- January 7 (Tuesday) <1376> Kaneko Seed Co. <6496> Nakakita Manufacturing <7445> Right-on <7679> Yakulodo HD <7975> Licht Lab <8931> Wada Kogyo <9842> Arclands ----------------------